Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Basic Net EPS Stands At $13

0

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) had an annual basic consolidated EPS of $13.0018 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $13.0018.

EPS from continuing operations

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported $13 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $13 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) received basic EPS of $13.0018 for the annual period ended 2015-12-31. EPS contribution from the parent company was $13.0018 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $13 was reported by Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $13.

Consolidated diluted EPS

For the period ended 2015-12-31, $12.121 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $12.121 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $12.12 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $12.12 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $12.12 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $12.12.

Diluted EPS from parent

Diluted EPS of $12.121 was received by Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $12.121 on quarterly basis. For the annual period ended 2015-12-31, $13 was posted by Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $13 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 19.79. But it was 19.79 for the quarter ended 2015-12-31. 21.228 and 21.228 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 15 times, 1 visits today)